Cargando…
Complete Remission of Recurrent Retroperitoneal Liposarcoma after the Administration of Gemcitabine and Docetaxel as First-Line Adjuvant Chemotherapy: A Case Report
Retroperitoneal liposarcoma is a rare type of cancer. Relapse after surgery is frequent, and relapsing tumors tend to be more aggressive and less differentiated each episode, worsening the prognosis. This report describes the case of a 42-year-old female diagnosed with retroperitoneal liposarcoma af...
Autores principales: | Da Silva, Filipe Rocha, Lima, Alan Vitor Jerônimo, Albuquerque, Erick Willian Rocha Pereira, Moreira-Silva, Carlos Augusto, De Oliveira, Nicole Maués Flexa, Ohana, Jorge Alberto Langbeck, Carvalho, Luís Eduardo Werneck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006640/ https://www.ncbi.nlm.nih.gov/pubmed/29928214 http://dx.doi.org/10.1159/000489393 |
Ejemplares similares
-
Retrospective evaluation of the role of gemcitabine‐docetaxel in well‐differentiated and dedifferentiated liposarcoma
por: Thirasastr, Prapassorn, et al.
Publicado: (2022) -
Retroperitoneal liposarcoma: the role of adjuvant radiation therapy and the prognostic factors
por: Lee, Hong Seok, et al.
Publicado: (2016) -
Giant retroperitoneal liposarcoma
por: Herrera-Gómez, Ángel, et al.
Publicado: (2008) -
Giant retroperitoneal liposarcoma
por: Gan, Yi, et al.
Publicado: (2012) -
Huge retroperitoneal liposarcoma
por: Akhoondinasab, Mohammad Reza, et al.
Publicado: (2011)